458 related articles for article (PubMed ID: 18495126)
1. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
[TBL] [Abstract][Full Text] [Related]
3. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites.
Debache K; Guionaud C; Alaeddine F; Hemphill A
Parasitology; 2010 Feb; 137(2):229-40. PubMed ID: 19835644
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
Srinivasan S; Mueller J; Suana A; Hemphill A
J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
[TBL] [Abstract][Full Text] [Related]
6. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
Alaeddine F; Keller N; Leepin A; Hemphill A
J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
[TBL] [Abstract][Full Text] [Related]
7. Intra-cisternal vaccination induces high-level protection against Neospora caninum infection in mice.
Debache K; Hemphill A
Vaccine; 2012 Jun; 30(28):4209-15. PubMed ID: 22537986
[TBL] [Abstract][Full Text] [Related]
8. RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection.
Monney T; Rütti D; Schorer M; Debache K; Grandgirard D; Leib SL; Hemphill A
Vaccine; 2011 Sep; 29(40):6967-75. PubMed ID: 21787824
[TBL] [Abstract][Full Text] [Related]
9. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
[TBL] [Abstract][Full Text] [Related]
10. Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice.
Rojo-Montejo S; Collantes-Fernández E; Regidor-Cerrillo J; Rodríguez-Bertos A; Prenafeta A; Gomez-Bautista M; Ortega-Mora LM
Vet Parasitol; 2011 Feb; 175(3-4):220-9. PubMed ID: 21067865
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum.
Ramamoorthy S; Lindsay DS; Schurig GG; Boyle SM; Duncan RB; Vemulapalli R; Sriranganathan N
J Eukaryot Microbiol; 2006; 53(2):151-6. PubMed ID: 16579818
[TBL] [Abstract][Full Text] [Related]
12. Immune response to Neospora caninum in naturally infected heifers and heifers vaccinated with inactivated antigen during the second trimester of gestation.
Moore DP; Leunda MR; Zamorano PI; Odeón AC; Romera SA; Cano A; de Yaniz G; Venturini MC; Campero CM
Vet Parasitol; 2005 Jun; 130(1-2):29-39. PubMed ID: 15893067
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.
Monney T; Debache K; Grandgirard D; Leib SL; Hemphill A
Vaccine; 2012 Oct; 30(46):6588-94. PubMed ID: 22940381
[TBL] [Abstract][Full Text] [Related]
14. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens.
Ramamoorthy S; Sanakkayala N; Vemulapalli R; Jain N; Lindsay DS; Schurig GS; Boyle SM; Sriranganathan N
Int J Parasitol; 2007 Nov; 37(13):1531-8. PubMed ID: 17575983
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model).
Ellis J; Miller C; Quinn H; Ryce C; Reichel MP
Vaccine; 2008 Nov; 26(47):5989-96. PubMed ID: 18789996
[TBL] [Abstract][Full Text] [Related]
16. The immune enhancement of a novel soy lecithin/β-glucans based adjuvant on native Neospora caninum tachyzoite extract vaccine in mice.
Mansilla FC; Franco-Mahecha OL; Lavoria MÁ; Moore DP; Giraldez AN; Iglesias ME; Wilda M; Capozzo AV
Vaccine; 2012 Feb; 30(6):1124-31. PubMed ID: 22178728
[TBL] [Abstract][Full Text] [Related]
17. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.
Tuo W; Zhao Y; Zhu D; Jenkins MC
Vaccine; 2011 Mar; 29(13):2392-9. PubMed ID: 21281689
[TBL] [Abstract][Full Text] [Related]
18. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens.
Ramamoorthy S; Sanakkayala N; Vemulapalli R; Duncan RB; Lindsay DS; Schurig GS; Boyle SM; Kasimanickam R; Sriranganathan N
Int J Parasitol; 2007 Nov; 37(13):1521-9. PubMed ID: 17568587
[TBL] [Abstract][Full Text] [Related]
19. Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum.
Bartley PM; Wright S; Chianini F; Buxton D; Innes EA
Parasitology; 2008 Jan; 135(Pt 1):13-21. PubMed ID: 17767798
[TBL] [Abstract][Full Text] [Related]
20. Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.
Jiménez-Ruiz E; Alvarez-García G; Aguado-Martínez A; Salman H; Irache JM; Marugán-Hernández V; Ortega-Mora LM
Vaccine; 2012 Jul; 30(33):4983-92. PubMed ID: 22640942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
